Watkins, David J.

Randomized phase 2 study of paclitaxel (PTX), trastuzumab (T) with or without MM-111 in HER2 expressing gastroesophageal cancers (GEC).

Denlinger, Crystal S. , Sym, Sun Jin , Bendell, Johanna C. , Kudla, Art, McDonagh, Charlotte F., Czibere, Akos, Chibaudel, Benoist , Yoon, Harry H. , Hecht, J. Randolph, Bang, Yung‐Jue, Maqueda, María , Watkins, David J. , Park, Se Hoon , Arkenau, Hendrik‐Tobias , Bekaii‐Saab, Tanios , Press, Michael F. , Cunningham, David , Bang, Yung‐Jue , Chibaudel, Benoist

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 4043-4043

10.1200/jco.2016.34.15_suppl.4043